JOE
HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Journal of Endocrinology (2009) 201, 1-13       DOI: 10.1677/JOE-08-0526
© 2009 Society for Endocrinology
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
JOE-08-0526v1
201/1/1    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hoffman, B. G
Right arrow Articles by Jones, S. J M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hoffman, B. G
Right arrow Articles by Jones, S. J M

REVIEW

Genome-wide identification of DNA–protein interactions using chromatin immunoprecipitation coupled with flow cell sequencing

Brad G Hoffman and Steven J M Jones1

Department of Cancer Endocrinology, BC Cancer Research Center, 675 West 10th Avenue, Vancouver, BC, Canada V5Z 1L31 Micheal Smith Genome Sciences Centre, BC Cancer Agency, Suite 100-570 West 7th Avenue, Vancouver, BC, Canada V5Z 4S6

(Correspondence should be addressed to S J M Jones; Email: sjones{at}bcgsc.ca)

The transcriptional networks underlying mammalian cell development and function are largely unknown. The recently described use of flow cell sequencing devices in combination with chromatin immunoprecipitation (ChIP-seq) stands to revolutionize the identification of DNA–protein interactions. As such, ChIP-seq is rapidly becoming the method of choice for the genome-wide localization of histone modifications and transcription factor binding sites. As further studies are performed, the information generated by ChIP-seq is expected to allow the development of a framework for networks describing the transcriptional regulation of cellular development and function. However, to date, this technology has been applied only to a small number of cell types, and even fewer tissues, suggesting a huge potential for novel discovery in this field.




This article has been cited by other articles:


Home page
J Mol EndocrinolHome page
K J Dudley, K Revill, R N Clayton, and W E Farrell
Pituitary tumours: all silent on the epigenetics front
J. Mol. Endocrinol., June 1, 2009; 42(6): 461 - 468.
[Abstract] [Full Text] [PDF]




HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2009 by the Society for Endocrinology.